Issued Patents 2023
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11850241 | Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea | Michael D. Kaufman, Scott Bone, Corey Bloom | 2023-12-26 |
| 11850240 | Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea | Michael D. Kaufman, Scott Bone, Corey Bloom | 2023-12-26 |
| 11844788 | Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea | Michael D. Kaufman, Scott Bone, Corey Bloom | 2023-12-19 |
| 11801237 | Amorphous kinase inhibitor formulations and methods of use thereof | Michael D. Kaufman, Scott Bone, Corey Bloom | 2023-10-31 |
| 11793795 | Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea | Michael D. Kaufman, Scott Bone, Corey Bloom | 2023-10-24 |
| 11612591 | Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea | Michael D. Kaufman, Scott Bone, Corey Bloom | 2023-03-28 |
| 11576903 | Amorphous kinase inhibitor formulations and methods of use thereof | Michael D. Kaufman, Scott Bone, Corey Bloom | 2023-02-14 |